UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003620
Receipt number R000004362
Scientific Title Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study
Date of disclosure of the study information 2010/05/17
Last modified on 2018/12/01 21:00:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study

Acronym

Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study

Scientific Title

Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study

Scientific Title:Acronym

Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study

Region

Japan


Condition

Condition

Acute Coronary Syndrome

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This is an exploratory study aiming to elucidate the mechanism underlying plaque stabilization of statin treatment using Optical Coherence Tomography

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

For the plaques evaluated by OCT, what are the differences in plaque-stabilizing effects of atorvastatin in plaques with different characteristics (fibrous cap thickness)?

Key secondary outcomes

1. Are LDL-C and fibrous-cap thickness inversely-correlated?
2. Are plaque volume and fibrous-cap thickness inversely-correlated?
3. Does atorvastatin suppress new plaque formation?


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

10 to 20 mg pitavastatin daily started within 24 hours of PCI to maintain LDL-cho level less than 70mg/dl

Interventions/Control_2

Control

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Patients with acute coronary syndrome (including ST-segment elevation acute myocardial infarction, non-ST-segment elevation myocardial infarction and unstable angina).
2. Patients who have at least one critical stenosis involving 75% or more of the stenosis
3. LDL-cho level between 100mg/dl and 180mg/dl
4. Patients providing written consent for participation in this clinical trial on their own volition after receiving a thorough explanation about the study

Key exclusion criteria

1. Patients who will undergo elective percutaneous coronary intervention,
2. Patients who received thrombolytic therapy
3. Previous statin treatment
4. Severe left ventricular dysfunction (Ejection fraction <40% by echocardiogram),
5. Uncontrolled severe diabetes mellitus (HbA1c >12.0%).

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tohru Masuyama

Organization

Hyogo College of Medicine

Division name

Cardiovascular Division

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN

TEL

0798-45-6553

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kenichi Fujii

Organization

Hyogo College of Medicine

Division name

Cardiovascular Division

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN

TEL

0798-45-6553

Homepage URL


Email

kfujii@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine
Cardiovascular Division

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 05 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 05 Month 16 Day

Last modified on

2018 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004362


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name